期刊档案 · Multiple
Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 · OAE Publishing Inc. · UNITED STATES OF AMERICA · Quarterly · 创刊 2020
Extracellular Vesicles and Circulating Nucleic Acids 中科院新锐版 生物学 2区，影响因子 8.5（官网公布），完全开放获取，APC 约 2,600 美元，近 24 个月 100 篇文章投稿到接收中位 100 天，2025 年发文 67 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Extracellular Vesicles and Circulating Nucleic Acids 由 OAE Publishing Inc. 出版，属中科院生物学大类。按 OpenAlex 近年发文统计，该刊主要发表 Extracellular vesicles in disease、MicroRNA in disease regulation、interferon and immune responses 等主题的论文，这 3 个主题约占 61.7%，主导子领域为 Molecular Biology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Extracellular Vesicles and Circulating Nucleic Acids provides an online platform for the sharing of research data, new methodology, reviews and commentaries in the areas of extracellular vesicles and circulating nucleic acids including DNA, RNA, and miRNA and their therapeutic use. The journal is committed to the rapid publication of original findings that increase our understanding of the molecular and cell biology, biogenesis, and origin of extracellular vesicles and circulating nucleic acids; and their use as biomarkers for the diagnosis, prognostication and surveillance of disease states, and in therapeutics. Manuscripts with clinical relevance are especially encouraged to promote the translation from basic science to clinical applications. The criteria for acceptance are scientific excellence and originality. All works involving the use of animals and human subjects must have been approved by institutional review committees and adhere to accepted international ethical standards.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Multiple
主编 Yoke Peng Loh出版商官网
编委会国家分布：中国大陆 15 位（约 18%）；主要国家 美国 24、中国 15、韩国 5、意大利 5、澳大利亚 5（共 83 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology45.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology10.9%
- interferon and immune responsesImmunology and Microbiology5.5%
- Nanoplatforms for cancer theranosticsEngineering4.5%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology3.7%
- Mesenchymal stem cell researchMedicine3.5%
- Bacterial Infections and VaccinesImmunology and Microbiology3.1%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology2.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）生物学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 生物学 | 2 区 |
| 小类 | 生化与分子生物学BIOCHEMISTRY & MOLECULAR BIOLOGY | 2 区 |
| 小类 | 细胞生物学CELL BIOLOGY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 8.5出版商官网 ·
- CiteScore 2026-06
- 6.6LetPub ·
- CiteScore（出版商公布）
- 6.6出版商官网 ·
- SJR 2026-06
- 1.44LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 76OpenAlex ·
- 两年平均被引
- 5.05OpenAlex ·
- 自引率
- 2.4%LetPub ·
- Gold OA 文章占比
- 75.93%LetPub ·
发文规模
- 年文章数
- 45LetPub ·
- 年发文量（出版商公布） 2027
- 2,027出版商官网 ·
- 年下载量（出版商公布）
- 252,692出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 285 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 80 | 75 | 121 |
| 2025 | 67 | 67 | 339 |
| 2024 | 43 | 43 | 499 |
| 2023 | 39 | 39 | 894 |
| 2022 | 31 | 31 | 404 |
| 2021 | 20 | 19 | 472 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
100 天投稿到接收中位数 · P25–P75 85 天 – 129 天
- 接收到上线
- 中位数 25 天（100 篇）
- 投稿到上线
- 中位数 130 天
- 样本
- 100 篇有投稿与接收日期的文章（窗口内共 123 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 编辑初审决定
- 10 天出版商官网 ·
- 投稿到首次决定
- 10 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取LetPub
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | USD 2,600 | — | — |
其他费用与减免（作者指南）
- 其他费用
- 收取，金额见官网
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
征稿中的专刊2 个，按截稿日期
出版商官网投稿准备要点8 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 3–8 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 推荐审稿人
- 可选
- 图文摘要
- 必须提供
- 投稿信（Cover letter）
- 必须提供
- 不接收
- preprint
接收的文章类型16 种
- commentaryThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- editorialThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- letterThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- letter to editorA Letter to Editor is usually an open post-publication review of a paper from its readers, often critical of some aspect of a published paper.未说明篇幅
- meta-analysisThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- mini reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- mini review/reviewA Mini Review/Review article should provide readers with an in-depth understanding of a field by summarizing existing literature, and highlight key gaps and cha…未说明篇幅
- opinionThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- original articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- perspectivePerspective is a format for scholarly reviews and discussions of the primary research literature that are too technical for a Commentary but do not meet the cri…未说明篇幅
- research highlightResearch Highlights discuss the main advances made by the paper as well as putting the finds of the study into the proper context of the field.未说明篇幅
- reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- review articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- short communicationsShort Communications are articles that present groundbreaking preliminary results or significant findings that are part of a larger study over multiple years.未说明篇幅
- systematic reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
- viewpointThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 2.3.3.4 AI and AI-assisted tools Statement
作者应在稿件中披露人工智能及AI辅助技术的使用情况；如稿件不涉及此问题，应在该部分注明“不适用”。 模型中文摘要
Authors should disclose in their manuscript the use of AI and AI-assisted technologies. Declaring the use of these technologies supports transparency and trust between authors, readers, reviewers, editors and contributors and facilitates compliance with the terms of use of the relevant tool or technology.If the manuscript does not involve this issue, state “Not applicable.” in this section.
原文 ↗出版商官网 ·- 作者资格 4. Authorship
OAE期刊的作者身份仅基于对已发表研究的实质性贡献，需满足四项标准：对研究构思设计或数据获取、分析、解释有实质贡献；起草或对稿件进行重要学术内容修改；对最终发表版本进行最终批准；同意对工作的所有方面负责。 模型中文摘要
Authorship credit of OAE journals should be solely based on substantial contributions to a published study, as specified in the following four criteria:1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;2. Drafting the work or revising it critically for important intellectual content;3. Final approval of the ve…
原文 ↗出版商官网 ·- 利益冲突 2.3.3.6 Conflicts of Interest
作者必须申报任何可能被视为不当影响研究结果呈现或解释的潜在利益冲突；如无利益冲突，应声明“所有作者声明无利益冲突”；受保密协议约束的作者应声明因保密协议而无法披露利益冲突。 模型中文摘要
Authors must declare any potential conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there are no conflicts of interest, please state "All authors declared that there are no conflicts of interest." in this section. Some authors may be bound by confidentiality agreements. In such cases, in place of itemiz…
原文 ↗出版商官网 ·- 数据可用性 2.3.3.3 Availability of Data and Materials
为维护研究记录的完整性、透明度和可重复性，作者应在稿件中说明支持其研究结论的数据存放位置；数据可存入数据存储库或作为期刊补充信息发表；无法共享数据的作者应说明数据不予共享并解释原因；如稿件不涉及此问题，应注明“不适用”。 模型中文摘要
In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section in their manuscripts, detailing where the data supporting their findings can be found. Data can be deposited into data repositories or published as supplementary information in the journal. Authors who cannot share their data should state that the data will not be shared an…
原文 ↗出版商官网 ·- 出版伦理 2.3.3.7 Ethical Approval and Consent to Participate
涉及人类受试者、人体材料或人类数据的研究必须符合《赫尔辛基宣言》并经适当伦理委员会批准；应获得参与者或其父母/法定监护人（16岁以下儿童）的知情同意；稿件中必须写明伦理委员会名称（含参考编号）及所获知情同意；涉及动物和细胞系的研究必须包含伦理声明。 模型中文摘要
Research involving human subjects, human material or human data must be performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of the ethics committee (including the re…
原文 ↗出版商官网 ·- 许可与版权 1.2 Open Access and Copyright
期刊采用金色开放获取出版模式，内容以知识共享署名4.0国际许可协议发布，版权由作者保留。 模型中文摘要
The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.
原文 ↗出版商官网 ·- 开放获取 1.2 Open Access and Copyright
期刊采用金色开放获取出版模式，内容以知识共享署名4.0国际许可协议发布，版权由作者保留。 模型中文摘要
The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.
原文 ↗出版商官网 ·- 同行评审 7.3 AI Use in Peer Review
审稿人不得将稿件或材料上传至AI平台，以免违反保密政策、侵犯知识产权或泄露个人数据；同行评审必须由人类主导，AI工具不能取代批判性学术判断，审稿人不得用AI评估稿件；如评审的任何方面得到AI工具支持，审稿人须在报告中明确披露，并对报告承担全部责任。 模型中文摘要
Confidentiality requirements: Reviewers must not upload manuscripts/materials to AI platforms, as this: 1. Violates OAE’s confidentiality policies2. Risks intellectual property infringement3. May compromise personal data in identifiable content Review integrity standards: Peer review must remain human-driven – AI tools cannot replace critical scholarly judgment.Reviewers must not use AI for manusc…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 3.1.5 Trial Registration
OAE要求作者注册稿件中报告的所有相关临床试验，并遵循世界卫生组织对临床试验的定义，即任何前瞻性将人类受试者分配至一项或多项健康相关干预以评估健康结果影响的研究。 模型中文摘要
OAE requires all authors to register all relevant clinical trials that are reported in manuscripts submitted. OAE follows the World Health Organization (WHO)'s definition of clinical trials: "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions i…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- OAE Publishing Inc.
- 出版国家或地区
- UNITED STATES OF AMERICA
- 出版语言
- English
- 出版周期
- Quarterly
- 创刊年份
- 2020
- ISSN
- 2767-6641
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Extracellular Vesicles and Circulating Nucleic Acids 的常见问题
Extracellular Vesicles and Circulating Nucleic Acids 是中科院几区期刊？
2026 年新锐版分区表中为生物学 2区。不同版本与大小类分区不能混用。
Extracellular Vesicles and Circulating Nucleic Acids 的影响因子是多少？
期刊官网公布的影响因子为 8.5，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 6.6，h-index 为 26。
Extracellular Vesicles and Circulating Nucleic Acids 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）100 篇已发表文章登记的日期，投稿到接收的中位数为 100 天（四分位 85–129 天）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Extracellular Vesicles and Circulating Nucleic Acids 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：3–8 个；参考文献格式：顺序编码制（按引用顺序编号）；首次投稿格式：允许不按期刊格式排版（free format）；推荐审稿人：可选；图文摘要：必须提供；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Extracellular Vesicles and Circulating Nucleic Acids 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 83 位编委中，中国大陆 15 位（约 18%）；人数最多的国家是 美国（24 位）、中国（15 位）、韩国（5 位）。统计按编委会页面列出的机构国家计，仅供参考。
Extracellular Vesicles and Circulating Nucleic Acids 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Extracellular Vesicles and Circulating Nucleic Acids 被 ESCI、Scopus 收录。
Extracellular Vesicles and Circulating Nucleic Acids 是开放获取期刊吗？版面费多少？
Extracellular Vesicles and Circulating Nucleic Acids 为完全开放获取。APC 约 2,600 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。